Bio-Techne
TECH
343 hedge funds and large institutions have $7.32B invested in Bio-Techne in 2018 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 106 increasing their positions, 137 reducing their positions, and 42 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
38% more capital invested
Capital invested by funds: $5.31B → $7.32B (+$2.01B)
10% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 42
1% more funds holding
Funds holding: 341 → 343 (+2)
3.47% less ownership
Funds ownership: 383.66% → 380.19% (-3.5%)
15% less call options, than puts
Call options by funds: $3.1M | Put options by funds: $3.63M
23% less repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 137
Top Buyers
Top Sellers
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$66.3M |
| 2 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$53.4M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$40.7M |
| 4 |
Select Equity Group
New York
|
-$39.8M |
| 5 |
RA
Royce & Associates
New York
|
-$27M |
TECH Hedge Fund Activity: Q3 2018 in Review
343 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2018, worth a combined $7.32B — up 38% from $5.31B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new TECH positions and 42 closed out — a net gain of 4 holders — while 106 added to existing stakes and 137 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $137M. The largest seller was American Century Companies, cutting an estimated $66.3M.
- 343 institutional investors held Bio-Techne (TECH) as of Q3 2018, up from 341 in Q2 2018.
- Funds reported $7.32B of Bio-Techne stock for Q3 2018, up 38% quarter-over-quarter.
- 46 funds opened new Bio-Techne positions in Q3 2018 and 42 closed out, a net change of +4 holders.
- The largest Bio-Techne buyer in Q3 2018 was Wellington Management Group, an estimated $137M added.
- The largest Bio-Techne seller in Q3 2018 was American Century Companies, an estimated $66.3M sold.
Based on aggregated 13F filings for Q3 2018.